Driehaus Capital Management’s Guardant Health GH Stock Holding History

Driehaus Capital Management’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$230M	Buy	1,533,985 +9,703	+0.6%	+$1.06M	1.33%	9
2026 Q1	$141M	Sell	1,524,282 -618,911	-29%	-$62.1M	1.04%	13
2025 Q4	$219M	Sell	2,143,193 -9,122	-0.4%	-$816K	1.49%	4
2025 Q3	$134M	Sell	2,152,315 -323,298	-13%	-$17.6M	0.96%	12
2025 Q2	$129M	Buy	2,475,613 +542,527	+28%	+$24.2M	1.03%	12
2025 Q1	$82.3M	Buy	+1,933,086	New	+$83.4M	0.79%	25
2021 Q3	–	Sell	-65,614	Closed	-$8.15M	–	426
2021 Q2	$8.15M	Buy	65,614 +9,245	+16%	+$1.24M	0.11%	242
2021 Q1	$8.61M	Sell	56,369 -24,307	-30%	-$3.67M	0.13%	221
2020 Q4	$10.4M	Buy	80,676 +7,080	+10%	+$815K	0.17%	174
2020 Q3	$8.23M	Buy	73,596 +34,707	+89%	+$3.17M	0.17%	155
2020 Q2	$3.15M	Buy	38,889 +1,172	+3%	+$94.4K	0.08%	232
2020 Q1	$2.63M	Sell	37,717 -11,949	-24%	-$917K	0.09%	203
2019 Q4	$3.88M	Buy	49,666 +121	+0.2%	+$8.72K	0.1%	210
2019 Q3	$3.16M	Sell	49,545 -1,368	-3%	-$121K	0.1%	207
2019 Q2	$4.39M	Buy	50,913 +15,125	+42%	+$1.16M	0.14%	176
2019 Q1	$2.75M	Sell	35,788 -54,209	-60%	-$3.01M	0.1%	196
2018 Q4	$3.38M	Buy	+89,997	New	+$3.32M	0.14%	169

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Driehaus Capital Management's GH Position: Q2 2026 in Review

Driehaus Capital Management increased its Guardant Health (GH) stake by 0.64% in Q2 2026, buying an estimated $1.06M and bringing the position to 1,533,985 shares worth $230M. The position accounts for 1.33% of the portfolio, ranked #9.

Driehaus Capital Management first reported a position in GH in Q4 2018 and has held it in 17 quarters since. 598 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Driehaus Capital Management held 1,533,985 shares of Guardant Health worth $230M as of Q2 2026.
Driehaus Capital Management bought 9,703 Guardant Health shares in Q2 2026, an estimated $1.06M.
Guardant Health made up 1.33% of Driehaus Capital Management's portfolio in Q2 2026, its #9 holding.
Driehaus Capital Management first reported a position in Guardant Health in Q4 2018 and has held it in 17 quarters since.
598 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Driehaus Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.